Małgorzata Pawlikowska

Małgorzata serves as the Head of Clinical Study Department at Pure Clinical. She specializes in medical devices, IVD, clinical investigations, performance studies, and usability testing. She is responsible for overseeing clinical and analytical performance studies, developing study protocols and research documentation in compliance with ICH-GCP, IVDR 2017/746, FDA, and other relevant regulatory requirements. Her responsibilities also include data analysis and ensuring that all projects are conducted in accordance with current guidelines and quality standards. She has over 14 years of experience in the scientific and research sector, with expertise in designing and scientifically coordinating performance studies for medical devices. Małgorzata holds a PhD in Biological Sciences, a Master’s degree in Biotechnology from Nicolaus Copernicus University in Toruń, and postgraduate studies in Clinical Trial Management and Monitoring from Kozminski University in Warsaw.

Małgorzata Pawlikowska

Małgorzata Pawlikowska

Head of Clinical Study Department

Education (5)

Kozminski University

Postgraduate Studies, Conducting and Monitoring of Clinical TrialsPostgraduate Studies, Conducting and Monitoring of Clinical Trials

X 2022 – VI 2023

Uniwersytet Mikołaja Kopernika w Toruniu

Doctor of Philosophy - PhD, Biological Sciences

X 2008 – VI 2013

Uniwersytet WSB Merito Toruń

Quality management

X 2009 – VI 2010

Max Planck Institute of Immunobiology and Epigenetics

InternshipInternship

IX 2007 – IV 2008

Uniwersytet Mikołaja Kopernika w Toruniu

Master of Science - MS, BiotechnologyMaster of Science - MS, Biotechnology

X 2006 – VI 2008

Work Experience (4)

Pure Clinical

Senior Clinical Research Scientist

II 2024 - currently

Clinical Research Scientist

III 2023 – II 2024

Nicolaus Copernicus University

Assistant Professor

X 2019 – II 2023

Research Assistant

I 2014 – XI 2019

Immquest Sp. z o.o.

Lab Advisor

VI 2016 – VII 2019

BPIC Sp. z o.o.

Certification Specialist

X 2011 – XII 2013

Publications (5)

Pawlikowska M et al. Fever-range hyperthermia inhibits cells immune response to protein-bound polysaccharides derived from Coriolus versicolor extract. Mol Immunol. 2016 Dec;80:50-57. doi: 10.1016/j.molimm.2016.10.013. Epub 2016 Nov 5. PMID: 27825050

Pawlikowska M et al. Protein-Bound Polysaccharides from Coriolus Versicolor Induce RIPK1/RIPK3/MLKL-Mediated Necroptosis in ER-Positive Breast Cancer and Amelanotic Melanoma Cells. Cell Physiol Biochem. 2020 Jun 13;54(4):591-604. doi: 10.33594/000000242. PMID: 32531147.

Pawlikowska M et al. Coriolus versicolor-derived protein-bound polysaccharides trigger the caspase-independent cell death pathway in amelanotic but not melanotic melanoma cells. Phytother Res. 2020 Jan;34(1):173-183. doi: 10.1002/ptr.6513. Epub 2019 Sep 12. PMID: 31515931.

Pawlikowska M et al. Pigmentation Levels Affect Melanoma Responses to Coriolus versicolor Extract and Play a Crucial Role in Melanoma-Mononuclear Cell Crosstalk. Int J Mol Sci. 2021 May 27;22(11):5735. doi: 10.3390/ijms22115735. PMID: 34072104; PMCID: PMC8198516.

Jędrzejewski T, Pawlikowska M et al. COVID-19 and Cancer Diseases-The Potential of Coriolus versicolor Mushroom to Combat Global Health Challenges. Int J Mol Sci. 2023 Mar 2;24(5):4864. doi: 10.3390/ijms24054864. PMID: 36902290; PMCID: PMC10003402.